title: Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis.
authors.forename: Philip T
authors.initials: PT
authors.lastname: Murphy
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Fay
authors.forename: Ronan T
authors.initials: RT
authors.lastname: Swords
authors.forename: John P
authors.initials: JP
authors.lastname: Quinn
authors.forename: John R
authors.initials: JR
authors.lastname: O'Donnell
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000139:chemically induced*
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate